{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dementia/diagnosis/clinical-features/","result":{"pageContext":{"chapter":{"id":"565bac2a-ada3-5b0a-ab7d-6681501b2c4a","slug":"clinical-features","fullItemName":"Clinical features","depth":2,"htmlHeader":"<!-- begin field 3e4e4c40-8e4e-4a9a-b995-60c194075141 --><h2>When should I suspect dementia?</h2><!-- end field 3e4e4c40-8e4e-4a9a-b995-60c194075141 -->","summary":"","htmlStringContent":"<!-- begin item 0c1cbab2-dfe2-4419-8878-73209ba0eb4c --><!-- begin field 50643518-9eb3-4f5b-8f5d-ded71e8c2b91 --><ul><li>Dementia can be difficult to identify as it usually has an insidious onset and non-specific signs and symptoms, which vary from person to person. People with early dementia may deny symptoms or accommodate to cognitive change and functional ability.</li><li><strong>Suspect dementia if any of the following are reported by the person and/or their family/carer:</strong><ul><li><strong>Cognitive impairment, including:</strong><ul><li>Memory problems — the person may defer to family when answering questions, have difficulty learning new information or remembering recent events or people's names, be vague with dates, and/or miss appointments.  </li><li>Receptive or expressive dysphasia.</li><li>Difficulty in carrying out coordinated movements such as dressing.</li><li>Disorientation and unawareness of the time and place.</li><li>Impairment of executive function, such as difficulties with planning and problem solving.</li></ul></li><li><strong>Behavioural and psychological symptoms of dementia (BPSD) tend to fluctuate, may last for 6 months or more and include:</strong><ul><li>Psychosis — the person may have delusions (which may be persecutory) and/or hallucinations (visual and auditory).</li><li>Agitation and emotional lability — the person may be easily upset, argumentative, shout, have mood swings, and/or be physically and verbally aggressive.</li><li>Depression and anxiety — the person may follow their carer around. The onset of depression in later life is a warning sign of dementia.</li><li>Withdrawal or apathy.</li><li>Disinhibition — the person may exhibit social or sexually inappropriate behaviour. </li><li>Motor disturbance — wandering, restlessness, pacing, and repetitive activity may be reported.</li><li>Sleep cycle disturbance or insomnia.</li><li>Tendency to repeat phrases or questions.</li></ul></li><li><strong>Difficulties with activities of daily living (ADLs):</strong><ul><li>In the early stages of dementia this may lead to neglect of household tasks, nutrition (causing weight loss), personal hygiene, and grooming. People with dementia who are in employment may find that they are increasingly making mistakes at work.</li><li>In the later stages, basic ADLs such as dressing, eating, and walking become affected.</li></ul></li></ul></li><li><strong>Symptoms related to specific subtypes of dementia include:</strong><ul><li><strong>For Alzheimer’s disease:</strong><ul><li>Early impairment of episodic memory — this may include memory loss for recent events, repeated questioning, and difficulty learning new information.</li></ul></li><li><strong>For vascular dementia:</strong><ul><li>Stepwise increases in the severity of symptoms — subcortical ischaemic vascular dementia may present insidiously with gait and attention problems and changes in personality.</li><li>Focal neurological signs (such as hemiparesis or visual field defects) may be present.</li></ul></li><li><strong>For dementia with Lewy bodies:</strong><ul><li>Repeated falls, syncope or transient loss of consciousness, severe sensitivity to antipsychotics, delusions, and hallucinations may be present. Memory impairment may not be apparent in early stages.</li><li>Parkinsonian motor features (such as shuffling gait, rigidity, slow movement [bradykinesia], and loss of spontaneous movement) and autonomic dysfunction (such as postural hypotension, difficulty in swallowing, and incontinence or constipation) may be present.</li></ul></li><li><strong>For frontotemporal dementia (FTD):</strong><ul><li>Personality change and behavioural disturbance (such as apathy or social/sexual disinhibition) may develop insidiously.</li><li>Other cognitive functions (such as memory and perception) may be relatively preserved.</li></ul></li></ul></li></ul><!-- end field 50643518-9eb3-4f5b-8f5d-ded71e8c2b91 --><!-- end item 0c1cbab2-dfe2-4419-8878-73209ba0eb4c -->","topic":{"id":"de9cbb4d-2d69-500f-be27-dc83f76dc3ba","topicId":"2491e3e7-cc21-42b9-8972-e54804b4782f","topicName":"Dementia","slug":"dementia","lastRevised":"Last revised in October 2020","chapters":[{"id":"af834011-0042-530a-8f9a-acd5828e0a34","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a0360b83-4555-5079-897f-12b2d555c1af","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"52cd8e36-39cd-5259-8819-bd96087b0265","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"60bd6b27-027f-56a6-a018-a1d694a6a2f3","slug":"changes","fullItemName":"Changes"},{"id":"7ced1224-30c2-5f30-9caf-3764f3665ae4","slug":"update","fullItemName":"Update"}]},{"id":"fae05cff-ad98-52fa-89b4-b97369195d59","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2f3b4bd3-e7cf-5492-afe0-0a5b230eab7e","slug":"goals","fullItemName":"Goals"},{"id":"9104785e-e491-5ca3-b3d3-7e951385bce9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a9c56eb4-bc0e-51cc-b486-a54c23906bc0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebf62eba-a4cd-536c-8c9f-c9505b0e7482","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a71b8dc2-79f8-5d24-b668-c792abc5a624","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c87232ba-6926-5ff2-98d2-f8839b0c0d37","slug":"nice-quality-standards","fullItemName":"NICE Quality Standards"}]},{"id":"825c29c3-9d55-54ae-b54d-8ee2ac796e97","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"46c6316f-eec0-580a-80ec-2112d2f0122f","slug":"definition","fullItemName":"Definition"},{"id":"f485482d-0d4e-52cb-9df4-3548bc72a566","slug":"causes","fullItemName":"Causes"},{"id":"87101d89-6073-57cc-b247-48be586ef185","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"58f6ec5a-c90b-5e64-a476-fc9fca39c6ae","slug":"prevalence","fullItemName":"Prevalence"},{"id":"994469e3-f824-5f48-b755-7f74dd360680","slug":"prognosis","fullItemName":"Prognosis"},{"id":"718f9ed4-d725-5f6e-a86f-5df88719cd52","slug":"complications","fullItemName":"Complications"}]},{"id":"366bcbe3-827a-5e08-9d81-8de84e46fefd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"565bac2a-ada3-5b0a-ab7d-6681501b2c4a","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"4c0fe55f-40c9-5a1c-8cf3-1ec8d88406d5","slug":"assessment","fullItemName":"Assessment"},{"id":"ef7780bd-8e94-5f95-870f-92ab930c4365","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3069f5e5-519f-50ec-81b7-c8948a5b3117","fullItemName":"Management","slug":"management","subChapters":[{"id":"c6c0cbc2-18fc-5bf8-973d-bc38b9001f28","slug":"suspected-dementia","fullItemName":"Scenario: Suspected dementia"},{"id":"6320a2da-e9d6-5f57-94d9-0433261edf89","slug":"follow-up-of-confirmed-dementia-in-primary-care","fullItemName":"Scenario: Follow up of confirmed dementia in primary care"},{"id":"343a59fa-439e-5ab9-9d3b-28a893d55d2f","slug":"management-of-end-stage-dementia","fullItemName":"Scenario: Management of end-stage dementia"}]},{"id":"9a2639de-07aa-5fe3-8f09-5c005f9c29dd","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"58ed8441-e3ca-566e-9afb-92a5ba60b1dd","slug":"haloperidol","fullItemName":"Haloperidol"},{"id":"67092bd7-2ab4-5e8b-8ead-5301454da4a8","slug":"acetylcholinesterase-inhibitors","fullItemName":"Acetylcholinesterase inhibitors"},{"id":"f4ced652-a6de-5e19-ae37-6de43dfd8104","slug":"lorazepam","fullItemName":"Lorazepam"},{"id":"45d5f01b-c1c2-53dc-91b4-8f7a90983fd5","slug":"memantine-hydrochloride","fullItemName":"Memantine hydrochloride"}]},{"id":"1e87c908-2ab5-5cba-8d6a-958c03f7a6cd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fc7a2bcf-854b-5ca4-9b02-2dcaaebe1162","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7bcb26a3-cc69-5201-9fd9-6353e27b412f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0c383917-58d0-5036-8217-5d9fd81cb2cb","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"fdb8af52-aeee-52bd-be79-c5534939d42f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a9f930f3-f8b6-5c8f-b8ca-b3155e0c23d3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"668c11fa-1873-58d4-b0e2-3eab90e8fbff","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"67c4aef9-fbf4-5bf6-8dc5-c501f74b1fe3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"366bcbe3-827a-5e08-9d81-8de84e46fefd","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"4bc315ff-ffe6-5452-9310-24500f6643a8","slug":"basis-for-recommendation-2cb","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 6e11ee0f-20dd-4784-8722-1f6123d2c3a7 --><h3>Basis for recommendation</h3><!-- end field 6e11ee0f-20dd-4784-8722-1f6123d2c3a7 -->","summary":null,"htmlStringContent":"<!-- begin item 2cb5a605-a7f9-4c67-82c0-52aa7694c063 --><!-- begin field 03ece3c0-42fa-4ce9-99b7-f384f3ccc12c --><p>The information on the clinical features of dementia is based on the National Institute for Health and Care Excellence (NICE) guideline <em>Dementia: supporting people with dementia and their carers in health and social care (CG42)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE, 2006</a>], the <em>European Federation of Neurological Societies (EFNS-ENS) guidelines on the diagnosis and management of disorders associated with dementia</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Sorbi, 2012</a>], the Guidelines and Protocols Advisory Committee (GPAC) guideline <em>Cognitive impairment: recognition, diagnosis and management in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">GPAC, 2014</a>], the World Health Organization fact sheet <em>Dementia</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">WHO, 2016</a>], and expert opinion in review articles on dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">O'Brien et al, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">McKeith et al, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Grand, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Young, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Kales, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Winblad, 2016</a>].</p><!-- end field 03ece3c0-42fa-4ce9-99b7-f384f3ccc12c --><!-- end item 2cb5a605-a7f9-4c67-82c0-52aa7694c063 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}